Bank of New York Mellon’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-320,326
Closed -$104M 4317
2024
Q1
$104M Sell
320,326
-9,766
-3% -$2.4M 0.02% 636
2023
Q4
$62.9M Sell
330,092
-5,172
-2% -$977K 0.01% 902
2023
Q3
$66.8M Sell
335,264
-4,533
-1% -$1.07M 0.01% 819
2023
Q2
$97M Sell
339,797
-12,558
-4% -$3.49M 0.02% 638
2023
Q1
$76.4M Sell
352,355
-8,865
-2% -$1.73M 0.02% 751
2022
Q4
$74.3M Sell
361,220
-7,493
-2% -$1.89M 0.02% 747
2022
Q3
$103M Buy
368,713
+25,770
+8% +$6.55M 0.02% 584
2022
Q2
$65.6M Buy
342,943
+191,705
+127% +$33.8M 0.02% 818
2022
Q1
$31.4M Buy
151,238
+3,771
+3% +$622K 0.01% 1402
2021
Q4
$26.3M Sell
147,467
-715
-0.5% -$141K ﹤0.01% 1558
2021
Q3
$30.5M Buy
148,182
+10,721
+8% +$2.1M 0.01% 1468
2021
Q2
$26.1M Buy
137,461
+24,025
+21% +$3.93M 0.01% 1577
2021
Q1
$14.8M Sell
113,436
-11,367
-9% -$1.36M ﹤0.01% 1881
2020
Q4
$12.9M Buy
124,803
+730
+0.6% +$63.2K ﹤0.01% 1868
2020
Q3
$9.4M Buy
124,073
+23,729
+24% +$1.35M ﹤0.01% 1885
2020
Q2
$4.75M Buy
100,344
+16,509
+20% +$680K ﹤0.01% 2226
2020
Q1
$2.78M Buy
83,835
+10,094
+14% +$401K ﹤0.01% 2371
2019
Q4
$3.24M Buy
73,741
+52,293
+244% +$1.93M ﹤0.01% 2563
2019
Q3
$642K Sell
21,448
-5,231
-20% -$222K ﹤0.01% 3398
2019
Q2
$1.52M Buy
+26,679
New +$1.3M ﹤0.01% 2962

Other funds holding SWAV

Bank of New York Mellon's SWAV Position: Q2 2024 in Review

Bank of New York Mellon sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 320,326 shares — an estimated $104M sold.

Bank of New York Mellon first reported a position in SWAV in Q2 2019 and held it in 20 quarters. The position peaked at $104M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Bank of New York Mellon reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 320,326 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $104M.
  • Bank of New York Mellon first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 20 quarters.
  • Bank of New York Mellon's Shockwave Medical, Inc. Common Stock position peaked at $104M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.